Cargando…
Illuminating COVID-19 lung disease through autopsy studies
Autores principales: | Meyerholz, David K., McCray, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332440/ https://www.ncbi.nlm.nih.gov/pubmed/32629393 http://dx.doi.org/10.1016/j.ebiom.2020.102865 |
Ejemplares similares
-
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
por: Li, Kun, et al.
Publicado: (2021) -
Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome
por: Meyerholz, David K., et al.
Publicado: (2016) -
Autopsy registry can facilitate COVID‐19 research
por: von Stillfried, Saskia, et al.
Publicado: (2020) -
The autopsy debate during the COVID-19 emergency: the Italian experience
por: Sapino, Anna, et al.
Publicado: (2020) -
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease
por: Strub, Matthew D., et al.
Publicado: (2020)